@Denial
I think the key will be FDA guidance on DMOAD and feedback from the FDA on the 008 results. If positive, then PAR could start trending upwards similar to CU6 which entered into a very strong uptrend following positive FDA guidance in July (in a down market).
- Forums
- ASX - By Stock
- PAR
- Chart
Chart, page-3974
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $81.36M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25818 | 0.235 |
8 | 99346 | 0.225 |
6 | 64676 | 0.220 |
8 | 190313 | 0.215 |
14 | 559696 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 141103 | 6 |
0.245 | 72877 | 3 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online